| Basal insulin and cardiovascular and other outcomes in dysglycemia ORIGIN Trial Investigators New England Journal of Medicine 367 (4), 319-328, 2012 | 2028 | 2012 |
| Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets K Maedler, P Sergeev, F Ris, J Oberholzer, HI Joller-Jemelka, GA Spinas, ... The Journal of clinical investigation 110 (6), 851-860, 2002 | 1692 | 2002 |
| Distinct effects of saturated and monounsaturated fatty acids on β-cell turnover and function K Maedler, GA Spinas, D Dyntar, W Moritz, N Kaiser, MY Donath Diabetes 50 (1), 69-76, 2001 | 775 | 2001 |
| Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic β-cell turnover and function K Maedler, J Oberholzer, P Bucher, GA Spinas, MY Donath Diabetes 52 (3), 726-733, 2003 | 740 | 2003 |
| The CORE Diabetes Model: projecting long-term clinical outcomes, costs and costeffectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and … AJ Palmer, S Roze, WJ Valentine, ME Minshall, V Foos, FM Lurati, ... Current medical research and opinion 20 (sup1), S5-S26, 2004 | 618 | 2004 |
| Glucose induces β-cell apoptosis via upregulation of the Fas receptor in human islets K Maedler, GA Spinas, R Lehmann, P Sergeev, M Weber, A Fontana, ... diabetes 50 (8), 1683-1690, 2001 | 543 | 2001 |
| Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial I Aeberli, PA Gerber, M Hochuli, S Kohler, SR Haile, I Gouni-Berthold, ... The American journal of clinical nutrition 94 (2), 479-485, 2011 | 470 | 2011 |
| Validation of the CORE Diabetes Model against epidemiological and clinical studies AJ Palmera, S Rozea, WJ Valentinea, ME Minshallb, V Foosa, FM Luratia, ... Current Medical Research and Opinion 20 (sup1), S27-S40, 2004 | 354 | 2004 |
| Superiority of small islets in human islet transplantation R Lehmann, RA Zuellig, P Kugelmeier, PB Baenninger, W Moritz, ... Diabetes 56 (3), 594-603, 2007 | 344 | 2007 |
| Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients S Kumar, AJM Boulton, H Beck-Nielsen, F Berthezene, M Muggeo, ... Diabetologia 39, 701-709, 1996 | 340 | 1996 |
| “European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses D P Mikhailidis, M Elisaf, M Rizzo, K Berneis, B Griffin, A Zambon, ... Current vascular pharmacology 9 (5), 533-571, 2011 | 328 | 2011 |
| Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families P Concannon, HA Erlich, C Julier, G Morahan, J Nerup, F Pociot, JA Todd, ... Diabetes 54 (10), 2995-3001, 2005 | 317 | 2005 |
| Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. GA Spinas, U Keller, M Brockhaus The Journal of clinical investigation 90 (2), 533-536, 1992 | 287 | 1992 |
| Glucose and palmitic acid induce degeneration of myofibrils and modulate apoptosis in rat adult cardiomyocytes D Dyntar, M Eppenberger-Eberhardt, K Maedler, M Pruschy, ... Diabetes 50 (9), 2105-2113, 2001 | 277 | 2001 |
| Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial I Aeberli, M Hochuli, PA Gerber, L Sze, SB Murer, L Tappy, GA Spinas, ... Diabetes care 36 (1), 150-156, 2013 | 262 | 2013 |
| Impact of physical activity on cardiovascular risk factors in IDDM R Lehmann, V Kaplan, R Bingisser, KE Bloch, GA Spinas Diabetes care 20 (10), 1603-1611, 1997 | 250 | 1997 |
| Serum cystatin C is sensitive to small changes in thyroid function P Wiesli, B Schwegler, GA Spinas, C Schmid Clinica chimica acta 338 (1-2), 87-90, 2003 | 245 | 2003 |
| Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. P Panina-Bordignon, R Lang, PM van Endert, E Benazzi, AM Felix, ... The Journal of experimental medicine 181 (5), 1923-1927, 1995 | 221 | 1995 |
| COVID-19 and metabolic disease: mechanisms and clinical management C Steenblock, PEH Schwarz, B Ludwig, A Linkermann, P Zimmet, ... The lancet Diabetes & endocrinology 9 (11), 786-798, 2021 | 220 | 2021 |
| Loss of abdominal fat and improvement of the cardiovascular risk profile by regular moderate exercise training in patients with NIDDM R Lehmann, A Vokac, K Niedermann, K Agosti, GA Spinas Diabetologia 38, 1313-1319, 1995 | 204 | 1995 |
